ArticleResearch (Washington, D.C.)2026
Artificial Intelligence Decodes Brain Elemental Signatures to Stratify Aging and Neurological Diseases.
Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The elemental composition of brains changes progressively with age, yet these metallome alterations remain largely unexplored as diagnostic biomarkers in neurological disease. Here, we present a comprehensive analysis of 24 inorganic elements in paired cerebrospinal fluid and serum samples from 1,608 individuals spanning healthy aging through 14 neurological conditions, representing the largest systematically standardized cohort for neurological metallomics. Uniquely, our unselected, consecutively admitted clinical cohort captures the full heterogeneity of neurological presentations, overcoming the limitations of traditional case-control designs focused on isolated disease entities. Machine learning analysis reveals that aging is associated with distinct cerebrospinal fluid elemental signatures independent of peripheral blood changes, primarily reflecting blood-brain barrier permeability alterations that correlate with established albumin quotient measurements. We identify 2 predominant patterns of neurological elemental dysregulation: one mainly consistent with passive barrier-mediated leakage in inflammatory conditions, and another mainly indicative of disease-intrinsic perturbations of metal homeostasis in neurodegenerative disorders. Age-stratified analysis reveals that elemental signatures evolve differently across the lifespan for distinct pathological processes. The integration of elemental signatures with routine clinical parameters through ensemble learning approaches enhances diagnostic accuracy across all tested neurological categories, establishing metallomics as a complementary biomarker class that captures orthogonal pathophysiological information. These findings establish brain metallomics as an emerging field where artificial intelligence reveals complex multi-element interactions present in neurological aging, opening new avenues for precision medicine in age-related neurological disorders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.